Medytox Ranks High in Search... Stock Price Down 6.76%
Medytoks was ranked among the top searched stocks on 2 days within the past month.
As of 2:30 PM on the 22nd, Medytoks is trading at 164,200 KRW, down 6.76% from the previous day. This represents a 31.55% decline compared to September 18. Medytoks is known as a manufacturer and seller of pharmaceuticals and cosmetic pharmaceuticals.
Today, foreigners have a tentative net sale of 12,000 shares of Medytoks, while institutions have a net purchase of 3,000 shares. Over the past 5 days, individual investors have net purchased 19,000 shares, whereas foreigners and institutions have net sold 8,965 shares and 17,333 shares, respectively.
On October 21, Medytoks became an issue in the market with the announcement of the 'Partner Parksin COVID-19 Vaccine Manufacturing and Commercialization Contract in Indonesia'↑...
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- Given Grants, Then Says "No Launch" ... Innovative Korean Technology Ultimately Forced Overseas
- [Breaking] Chairman Park Sookeun: "Possibility of Agreement Instead of Samsung Electronics Labor-Management Mediation Proposal"
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"


※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.